Public Access Records Office
The National Academies
500 5th Street NW
Room NAS 168
Washington, DC 20001
Tel: (202) 334-3543
FAX: (202) 334-2158
Email: paro@nas.edu
Project Information

Project Information


A National Strategy for Cancer Control in the United States


Project Scope:

An ad hoc committee under the auspices of the National Academies of Sciences, Engineering, and Medicine will examine cancer control efforts in the United States and recommend a national strategy to reduce the incidence, morbidity, and mortality from cancer and to improve quality of life for cancer survivors.  

The committee will review trends in cancer cases and outcomes in the United States as well as existing cancer control programs and initiatives across the cancer care continuum. Based on that review, the committee will consider potential actions to:

·         Establish comprehensive national goals for cancer control.

·         Identify potential mechanisms to evaluate and advance progress toward these goals.

·         Identify challenges to achieving these goals and highlight knowledge gaps that impede progress in cancer control

·         Foster collaboration and coordination among key stakeholders, clarifying roles in cancer control efforts, and to build on existing efforts and to develop and implement plans of action to overcome challenges.

·         Prioritize cancer control interventions that have the potential to achieve significant progress in improving population health and reducing health disparities.

 The committee will issue a report with findings and recommendations to achieve progress in developing and implementing a national cancer control strategy.

Status: Current

PIN: HMD-HCS-16-08

Project Duration (months): 18 month(s)

RSO: Madhavan, Guru

Board(s)/Committee(s):

Board on Health Care Services

Topic(s):

Health and Medicine


Committee Membership

Committee Post Date: 03/20/2018

Dr. Michael M. Johns - (Chair)
Michael Johns, M.D. (Chair), is chancellor emeritus, and professor of medicine and public health at Emory University. He was previously executive vice president for health affairs, and president, CEO, and chair of Emory Healthcare. He has also served as interim executive vice president for medical affairs at the University of Michigan, vice president of the medical faculty and dean of the Johns Hopkins School of Medicine, and on the faculty of University of Virginia and Walter Reed Army Medical Center. He is a member of the board of the Uniformed Services University of the Health Sciences, Vanderbilt University Medical Center, and the University of Michigan Health. He has also served on the advisory committee to the director of the Centers for Disease Control and Prevention, and on the editorial board of the Journal of the American Medical Association, and as editor of the Archives of Otolaryngology. He received his bachelor’s degree at Wayne State University, and graduated with a medical degree with distinction from the University of Michigan, where he also completed his residency training in otolaryngology, head and neck surgery. He is former president of the American Board of Otolaryngology. He has served on various boards, including Johnson & Johnson, the Genuine Parts Company, AMN Healthcare, West Health, Georgia Cancer Coalition, and the Blue Cross & Blue Shield of Maryland. His numerous honors include the Castle Connolly Lifetime Achievement Award, and an honorary doctorate of science from the University of Michigan. He is a member and former vice chair of the council of the National Academy of Medicine.
Dr. Katrina A. Armstrong
Katrina Armstrong, M.D., is the Jackson Professor of Clinical Medicine at Harvard Medical School, chair of the Department of Medicine and physician-in-chief of Massachusetts General Hospital. Previously, she was the chief of the Division of General Internal Medicine, associate director of the Abramson Cancer Center, and co-director of the Robert Wood Johnson Clinical Scholars Program at the University of Pennsylvania. She has been a fellow at the Leonard Davis Institute of Health Economics and senior scholar at the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania. She is chair of the external advisory panel of the Clinical Sequencing Exploratory Research Consortium of the National Human Genome Research Institute. Her honors include the Molly and Sidney N. Zubrow Award and the Robert Austrian Faculty Award from University of Pennsylvania School of Medicine, Warfield T. Longcope Prize for Excellence in Clinical Medicine from Johns Hopkins School of Medicine and Robert Wood Johnson Faculty Scholar Award. She is a graduate of Yale University and Johns Hopkins University School of Medicine. She is a fellow of the American College of Physicians, a member of the American Society of Clinical Investigation, and the National Academy of Medicine.
Dr. Smita Bhatia
Smita Bhatia, M.D., M.P.H., is Gay and Bew White Endowed Chair in Pediatric Oncology at the University of Alabama School of Medicine, where she is also the director of the Institute for Cancer Outcomes and Survivorship at the University of Alabama School of Medicine. She is also the associate director for outcomes research at the University of Alabama Comprehensive Cancer Center. She has served on editorial board of the Journal of Clinical Oncology. She obtained her M.B.B.S. and M.D. from the All India Institute of Medical Sciences, where she also completed her internship and residency. She received a M.P.H from the University of Minnesota, and completed her fellowship in blood banking, pediatric hematology/oncology, and bone marrow transplantation. She has served on the board of the American Society of Clinical Oncology. She is an elected member of the Association for American Physicians, American Pediatric Society, and the American Society for Clinical Investigation.
Dr. Betty R. Ferrell
Betty Ferrell, R.N., Ph.D., is a professor at City of Hope National Medical Center, where she directs the Division of Nursing Research and Education. Previously, she served on the faculty of nursing at University of Southern California and University of Oklahoma. She has been the co-chair of the National Consensus Project for Quality Palliative Care led by the National Coalition for Hospice and Palliative Care, the chair of the Southern California Cancer Pain Initiative, the president of the board of directors of the American Alliance of State Cancer Pain Initiatives. She has served on the advisory board of the Johns Hopkins Center for Cancer Pain Research, and is the editor-in-chief of the Journal of Hospice & Palliative Nursing. She received a B.S.N from Central State University, a Ph.D. from Texas Woman’s University, and a M.A. in theology, ethics, and culture from Claremont Graduate University. She is a recipient of the American Cancer Society Pathfinder in Palliative Care Award, and an honorary doctorate from University of Oklahoma. She has been a member of the board of scientific advisors of the National Cancer Institute and the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine. She is a fellow of the American Psychosocial Oncology Society and the American Academy of Nursing.
Jonathan E. Fielding, M.D., M.P.H., M.B.A.
Jonathan Fielding M.D., M.P.H., M.B.A., is a distinguished professor of health policy and management and pediatrics, in the Fielding School of Public Health and the Geffen School of Medicine, University of California, Los Angeles (UCLA). He is the founding co-director of the UCLA Center for Health Enhancement, Education and Research. He was a founding member of the U.S. Preventive Services Task Force, and is chair of the U.S. Community Preventive Services Task Force. He served as director of public health and health officer for Los Angeles County for 16 years. Before that, he was the Massachusetts Commissioner of Public Health. He has served as president and a regent for the American College of Preventive Medicine, and as a member of the National Commission on Prevention Priorities as well as on the advisory committee to the California State Department of Public Health. His honors include the Sedgwick Medal for Distinguished Service in Public Health, UCLA Medal, Milton and Ruth Roemer Prize for Creative Local Public Health Work, Fries Prize for Improving Health, Porter Prize for National Impact on Improving the Health of Americans, and Beverlee A. Myers Award for Excellence in Public Health, and a honorary fellowship from the Society for Public Health Education. He received his M.D., M.A. and M.P.H. from Harvard University, and his M.B.A. from the Wharton School of Business Administration. He is a member of the National Academy of Medicine.
Dr. Beverly A. Guadagnolo
Beverly Ashleigh Guadagnolo, M.D., M.P.H., is associate professor of radiation oncology and health services research at the University of Texas MD Anderson Cancer Center. She served as member of the U.S. Department of Health and Human Services advisory committee on minority health, and on the technical expert panel of the Agency for Health Care Research and Quality project on radiotherapy treatments for head and neck cancer. She received a B.A. in biology from the University of Texas at Austin, M.D. from Harvard Medical School, and M.P.H from the Harvard School of Public Health where she held a National Cancer Institute fellowship in cancer prevention.
Dr. Joseph Lipscomb
Joseph Lipscomb, Ph.D., is Georgia Cancer Coalition Distinguished Cancer Scholar and professor of health policy and management at the Rollins School of Public Health at Emory University. Previously, he was associate director for population sciences at Emory’s Winship Cancer Institute and a clinical investigator at the Kaiser Permanente Center for Health Research. He was also on the faculty of Duke University and the University of North Carolina at Chapel Hill, chief of the Outcomes Research Branch at the National Cancer Institute, and a study director at the National Academies of Sciences, Engineering, and Medicine. He has twice received the National Institutes of Health Award of Merit. He has served as a consultant in health economics, outcomes research, and program evaluation to American Cancer Society, SRA International, Amgen, Pfizer, Boehringer Ingelheim, Janssen, Dupont Merck, G.D. Searle, Society of Nuclear Medicine, Burroughs Wellcome, and PhRMA. He is chair of the Data and Evaluation Committee for the Georgia Cancer Control Consortium and is a member of the American College of Surgeons Commission on Cancer’s Quality Integration Committee, and was chair of American Cancer Society Health Services Research Advisory Committee. He received his B.A. from Vanderbilt University and Ph.D. from the University of North Carolina at Chapel Hill.
Dr. Maria E. Martinez
María Elena Martínez, Ph.D., M.P.H., is Sam M. Walton Endowed Chair for Cancer Research and professor of family and preventive medicine at the University of California, San Diego. She also serves as associate director of population sciences, disparities and community engagement at the Moores Cancer Center. Previously, she was professor of epidemiology in the Mel and Enid Zuckerman College of Public Health and was the Richard H. Hollen Professor of Cancer Prevention at the University of Arizona Cancer Center. She received a B.S. in nutrition from the University of Illinois, M.P.H. and a Ph.D. in epidemiology from the University of Texas School of Public Health. She completed a postdoctoral fellowship at the Harvard School of Public health. She is senior editor of the cancer disparities section for Cancer Epidemiology, Biomarkers & Prevention, and associated editor of the Journal of the National Cancer Institute. She has served as chair of the American Association for Cancer Research’s Minorities in Cancer Research Council, and was a member of the Cancer Moonshot Blue Ribbon Panel. She is a member of board of scientific advisors of the National Cancer Institute.
Ms. Mary S. McCabe
Mary McCabe, R.N., M.A., is former director of the Cancer Survivorship Program at Memorial Sloan-Kettering Cancer Center. She is a lecturer at Cornell Weill Medical College and Columbia University School of Nursing. She was chair of the Memorial Sloan-Kettering Cancer Center Ethics Committee and former director of nursing services at the Lombardi Cancer Center. She has been a director of the offices of clinical research promotion and of education and special initiatives at the National Cancer Institute, where she was also assistant director of the division of cancer treatment and diagnosis. She received her B.A. from Trinity College, B.S.N from Emory University, and M.A. from Catholic University. Her honors include the American Cancer Society Merit Award, Oncology Nursing Society Leadership Award, NIH Outstanding Performance Award, NIH Director’s Award, and Emory University’s Outstanding Alumnae Award. She is member of the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine.
Ms. Leah Merchant
Leah Merchant, B.A., serves as section supervisor for the Montana Cancer Control Programs in the Montana Department of Public Health and Human Services. Her responsibilities include managing regional contracts with local public health departments across Montana to implement cancer education outreach and direct screening services, and leading statewide implementations efforts to address cancer policy issues affecting diverse populations. She is past chair of the cancer council of the National Association of Chronic Disease Directors. She received her B.A. degree from Smith College.
Dr. Jewel Mullen
Jewel Mullen, M.D., M.P.H., M.P.A., is the former principal deputy assistant secretary for health at the U.S. Department of Health and Human Services. Previously, she served as commissioner of the Connecticut Department of Public Health. Earlier, she was director of the Bureau of Community Health and Prevention at the Massachusetts Department of Public Health, and former medical director of Baystate Mason Square Neighborhood Health Center. She began her clinical career as a member of the National Health Service Corps at Bellevue Hospital, New York, after which she joined the medical faculty of the University of Virginia. She has been a member of the medical staff at the Hospital of St. Raphael, the Yale University Health Services, and Yale New Haven Hospital. She received her B.S. and M.P.H. degrees from Yale University. She received her M.D. from the Mount Sinai School of Medicine and completed her internal medicine residency at University of Pennsylvania. She also received a M.P.A. from Harvard’s John F. Kennedy School of Government. She is former president of the Association of State and Territorial Health Officials.
Dr. Electra Paskett
Electra Paskett, Ph.D., is the Marion N. Rowley Professor of Cancer Research at the Ohio State University. She is also director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology, associate director for Population Sciences at the Comprehensive Cancer Center, and director of the Center for Cancer Health Equity at the Ohio State University. Previously, she was on the faculty of Wake Forest University School of Medicine and University of Missouri. She is past president of the American Society of Preventive Oncology and was chair of the American Public Health Association Cancer Forum. She is deputy editor of Cancer, Epidemiology, Biomarkers and Prevention and has served on the editorial boards of Cancer Prevention Research and Cancer. She received her B.S. from the University of Utah and Ph.D. from the University of Washington. She is recipient of the American Association for Cancer Research Dedication and Outstanding Achievement Award and the American Society of Preventive Oncology Distinguished Achievement Award. She is a fellow of the American Association for the Advancement of Science. She is a member of the National Cancer Advisory Board and has served as president of the American Society of Preventive Oncology.
Dr. George Poste
George Poste, Ph.D., D.V.M., is Regent’s Professor and Del E. Webb Chair of Health Innovation, and director and chief scientist of the Complex Adaptive Systems at Arizona State University, where he was also the founding director of the Biodesign Institute. Previously, he was chief science and technology officer and president of R&D among other leadership positions at SmithKline Beecham (now GlaxoSmithKline). Earlier, he was a principal cancer research scientist at Roswell Park Memorial Institute (now Roswell Park Comprehensive Cancer Center). He has served on the Defense Science Board and on boards of numerous companies including Health Longevity, Inc., Haplogen GmbH, Synthetic Genomics, Caris Life Sciences (as vice-chair), Exelexis, Illumina, Maxygen, diaDexus (as chair; acquired by VaxGen), Structural Genomix (as chair; acquired by Eli Lilly), and AdvancePCS (acquired by CVS), Burrill and Company, and Monsanto. He has been a trustee of the Gordon Research Conferences, Royal Society of Medicine Foundation, Institute for Scientific Information, and BP Technology Advisory Council. He has served as a distinguished fellow at the Hoover Institution of Stanford University and on the board of medical governors of the World Economic Forum. He has received honorary doctorates from the University of Bristol (where he received his D.V.M. and Ph.D.) and the University of Dundee. His awards include the Global Business Leadership Forum’s Einstein Award and the Pharmaceutical Industry Leadership Forum’s Scrip Lifetime Achievement Award. He is a member of the Council on Foreign Relations, and a fellow of the U.K. Royal College of Pathologists, the Royal College of Physicians, the Royal Society of Arts, the Academy of Medical Sciences, and the Royal Society. He is a Commander of the British Empire.
Dr. William B. Rouse
William Rouse, Ph.D., is the Alexander Crombie Humphreys Chair and director of the Center for Complex Systems and Enterprises at Stevens Institute of Technology. Previously, he was a professor in the School of Industrial and Systems Engineering at the Georgia Institute of Technology. He was chief executive officer of two software companies—Enterprise Support Systems and Search Technology. He has held faculty positions at University of Illinois, Delft University of Technology, and Tufts University. Among many advisory roles, he has served as a member of the U.S. Air Force Scientific Advisory Board, and a member of the Department of Defense Senior Advisory Group on Modeling and Simulation. He has received the Joseph Wohl Outstanding Career Award and the Norbert Wiener Award from the IEEE Systems, Man, and Cybernetics Society; a Centennial Medal and a Third Millennium Medal from IEEE; and the O. Hugo Schuck Award from the American Automation Control Council. He is a fellow of IEEE, International Council on Systems Engineering, Institute for Operations Research and Management Science, and the Human Factors and Ergonomics Society. He is a member of the National Academy of Engineering.
Dr. William W. Stead
William Stead, M.D., is chief strategy officer for Vanderbilt University Medical Center, where he also holds appointments as the McKesson Foundation Professor of Biomedical Informatics and Professor of Medicine. He has served as president of the American College of Medical Informatics and chair of the board of regents of the National Library of Medicine. He is a founding fellow of the American College of Medical Informatics and the American Institute for Medical and Biological Engineering, and served as founding editor-in-chief of the Journal of the American Medical Informatics Association. He received his B.A., M.D., and residency training in internal medicine and nephrology from Duke University. His awards include the Collen Award for Excellence in Medical Informatics and the Lindberg Award for Innovation in Informatics. He is chair of the National Committee for Vital and Health Statistics of the U.S. Department of Health and Human Services. He is a member and former councilor of the National Academy of Medicine.
Dr. Cornelia Ulrich
Cornelia Ulrich, Ph.D., is a Jon and Karen Huntsman Presidential Professor in Cancer Research at the University of Utah, where she is also senior director of population sciences at Huntsman Cancer Institute as well as professor and division chief of cancer population sciences in the Department of Population Health Sciences. She was on the faculty of University of Washington and was head of the Department of Preventive Oncology at the German Cancer Research Center and Director of the National Center for Tumor Diseases in Heidelberg, Germany. She was co-chair of the German Society of Epidemiology cancer group and a guest member of the committee for the implementation of the German Cancer Plan. She is senior editor for Cancer Epidemiology, Biomarkers & Prevention. She received her M.Sc. from Oregon State University and Ph.D. from University of Washington. She is a recipient of the American Association of Cancer Research Bristol-Myers Squibb Young Investigator Award, and is a fellow of the European Academy of Cancer Sciences.

Events



Location:

Arnold and Mabel Beckman Center
100 Academy Dr.
Irvine, California
Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Francis Amankwah
Contact Email:  cancercontrol@nas.edu
Contact Phone:  2023343093

Is it a Closed Session Event?
Yes



Location:

Keck Center
500 5th Street, NW
Washington D.C. 20001

Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Francis Amankwah
Contact Email:  cancercontrol@nas.edu
Contact Phone:  2023343093

Agenda
June 7, 2018; 8:45 am to 5:30 pm

HOW TO TRANSFORM CANCER CONTROL: A PUBLIC WORKSHOP

8:45 am The Spectrum of Cancer Control Michael Johns
9:00 am to 12:15 pm: Block I, What Have We Learned in the Past Decade?

Focus questions:
•What major insights, developments, and barriers have led to the current realities of understanding, practice, and policies across the cancer control continuum?
•How can policies and programmatic efforts that have not met their stated aspirations and goals for cancer control inform and guide our next steps?

9:00 am Block I, Part I
Moderated by: Mary McCabe and Jewell Mullen
Leslie Given, Strategic Health Concepts
Louise Russell, Rutgers University
Eric Feur, National Cancer Institute
Elizabeth Platz, Johns Hopkins Bloomberg School of Public Health

10:30 am Break

10:45 am Block I, Part II
Moderated by: Ashleigh Guadagnolo and Leah Merchant
Christopher Cogle, University of Florida, and Florida Cancer Control and Research Advisory Council
Julia Brody, Silent Spring Institute
Lee Schwartzberg, West Cancer Center, University of Tennessee
Holly Prigerson, Weill Cornell Medicine

12:15 pm Lunch (on your own; Keck cafeteria, 3rd floor)

1:15 pm to 4:45 pm: Block II, What Should We Be Doing Differently?
Focus questions:
• What strategic capabilities could maximize the scientific, technologic, clinical, field level, regulatory, and financial results, and their unified impact on cancer control?
• The current mismatches in goals and implementation as well as with the supporting information (technologies) across different stakeholder groups hinder progress throughout the cancer control continuum. What should be done differently?

1:15 pm Block II, Part I
Moderated by: William Rouse and William Stead
Jay Schnitzer, MITRE Corporation
Dennis McBride, Source America
George Hripcsak, Columbia University; New York-Presbyterian Hospital

2:45 pm Break

3:00 pm Block II, Part II
Moderated by: George Poste
Anna Barker, Arizona State University
Charles Phelps, University of Rochester

4:30 pm Public Comment
Moderated by: Michael Johns
5:00 pm Synthesis and Reflections

5:15 pm Adjourn
Is it a Closed Session Event?
No



Location:

Teleconference

Dial-in:1-855-880-1246
Meeting ID: 340-946-536
Event Type :  
-

Registration for Online Attendance :   
NA

Registration for in Person Attendance :   
NA


If you would like to attend the sessions of this event that are open to the public or need more information please contact

Contact Name:  Francis Amankwah
Contact Email:  cancercontrol@nas.edu
Contact Phone:  2023343093

Agenda
Public Teleconference Session with Study Sponsors
National Cancer Institute, Centers for Disease Control and Prevention, and American Cancer Society

April 12, 2018
3:00 pm to 4:00 pm
Dial-in Information:
Dial-in:1-855-880-1246
Meeting ID: 340-946-536
Chaired by: Michael Johns
Is it a Closed Session Event?
No


Publications

  • Publications having no URL can be seen at the Public Access Records Office
Publications

No data present.